Courtesy of Bill and Melinda Gates Foundation

Chalfont St Giles, UK and Stuttgart, Germany – December 14, 2011

GE Healthcare, the healthcare business of GE (NYSE: GE) and M+W Group, a leading global engineering, construction and project management company, announced today that the companies have formed a strategic alliance aimed at overcoming the lack of key biopharmaceuticals, especially in emerging nations.

Courtesy of Bill and Melinda Gates Foundation

The alliance, which will combine GE Healthcare’s expertise in technologies for biopharmaceutical manufacture with M+W Group’s global capabilities in bio-engineering and construction, will assist countries worldwide to become self-sufficient in the manufacture of vital biopharmaceuticals such as vaccines, insulin and biosimilars.

The Global Burden Courtesy of IDF Diabetes Atlas

Together, the companies will offer governments and pharmaceutical companies an integrated, cost-competitive “turn-key” approach for the construction of biopharmaceutical manufacturing plants, to help meet the rapidly increasing worldwide demand for these potentially life-saving treatments.

The alliance between the two companies aligns with GE’s healthymagination initiative, which focuses on reducing cost, increasing access and improving quality in healthcare.

As a globally operating company with an enviable track record in the execution of projects for the Life Science industry M+W Group is linking process technology, automation and complex facilities to integrated solutions. With a proud record in the execution of life science projects globally, M+W Group is bringing integrated solutions to process technology, automation and complex facility requirements. These comprehensive solutions are offered for: ·          pharmaceutical and biopharmaceutical industry ·          industrial biotechnology ·          medical device industry ·          food and nutrition industry ·          consumer and beauty care industry Whether your firm requires renovation, expansion, or turnkey construction of new life science facilities, we will find the best and most economical solutions to meet your deadlines. Courtesy of M+W Group GmbH

Worldwide demand for vaccines, insulin and other biopharmaceuticals such as antibodies to treat cancer and rheumatoid arthritis is increasing dramatically, driven by the global ageing population, rising obesity levels and the global effort to reduce the incidence of vaccine-preventable diseases.

Jürgen Wild, Chief Executive OfficerM+W Group GmbH Courtesy of M+W Group GmbH

Many countries have limited capabilities for the manufacture of these products, resulting in considerable unmet health needs.

According to the International Diabetes Federation, 366 million people have diabetes in 2011, predicted to rise to 552 million by 2030.

www.idf.org/diabetesatlas/5e/the-global-burden  

80% of people with diabetes live in low-and middle income countries, where insulin can be unaffordable and difficult to access.

On vaccination, the Gates Foundation estimates that worldwide, 21% of children do not have access to needed vaccines and that annually, 2.4 million children die from preventable diseases despite the availability of effective vaccines.

www.gatesfoundation.org/vaccines/Pages/overview.aspx  

The introduction of local “in country-for country” flexible manufacturing capabilities would help overcome this critical health gap.

Courtesy of Bill and Melinda Gates Foundation

Olivier Loeillot, General Manager of Enterprise Solutions, GE Healthcare Life Sciences said,
“We’re delighted to form this alliance with M+W Group, who share our vision of bringing affordable and flexible manufacturing capabilities to countries worldwide, especially the emerging nations. This is a big step forward in bringing better, more affordable healthcare to more people. M+W are one of the foremost global engineering companies in bioengineering. By working together to bring an integrated offering – from financing and construction of the plant, right through to training of the operational staff - we can make it much easier for governments to set up their own facilities.”

Courtesy of M+W Group GmbH

Dr. Tobias Lücke, the Managing Director of M+W Process Industries, specialized in Life Science solutions, said,
“Our global capabilities and strong track record over more than 18 years of delivering high technology facilities for the biotechnology industry is a great fit with the world-class bioprocessing expertise of GE Healthcare. Combining the experience and know-how of our respective companies will bring a new turnkey approach to the much needed local manufacture of potentially life-saving medicines and vaccines. We are delighted to be working together to make a real difference to healthcare delivery world-wide.”


About GE Healthcare


GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.

Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world.

Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE).

Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

For more information about GE Healthcare, visit our website at

www.gehealthcare.com  


About M+W Group


M+W Group is the leading global engineering, construction and project management company in the fields of Advanced Technology Facilities, Life Science & Chemicals, Energy & Environment Technologies and High-Tech Infrastructure.

From concept development to turnkey services the company manages projects of all sizes ensuring rapid realization, high quality standards and cost-effective completion.

With its competence to link process and automation technologies and complex facilities to integrated solutions M+W Group primarily focuses on leading companies in the fields of electronics, photovoltaics, life science, chemicals, energy, automotive, security and communication, as well as research institutes and universities.

M+W Group GmbH - Company Sculpture Night Courtesy of M+W Group GmbH

M+W Group GmbH is the holding company with headquarters in Stuttgart, Germany.

In 2010 M+W Group generated an order intake of 2.1 billion euros and revenues of nearly 1.8 billion euros with a workforce of approximately 6,000 employees.

M+W Group is owned by the Austrian Stumpf Group that is globally successful in the areas of High-Tech Engineering, Smart & Renewable Energy, Real Estate and Technology Investments.

For more detailed information on M+W Group visit

www.mwgroup.net  


Press Contacts

Dr Val Jones
GE Healthcare
+44 1494 498052
+44 7917 175192 (mobile)
val.jones@ge.com  


Source: General Electric Company

http://www.genewscenter.com/content/default.aspx  



ASTROMAN Magazine – 2011.12.11

GE, Microsoft to Launch Joint Venture Aimed at Global Healthcare System Transformation

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1117  


ASTROMAN Magazine – 2011.12.04

GE Healthcare Taps Global Industry Leader to Head Magnetic Resonance Business

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1113  


ASTROMAN Magazine – 2011.10.04

GE Healthcare Spotlights its Commitment to Advancing Cancer Care at ASTRO 2011

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1071  


ASTROMAN Magazine – 2011.10.27

Texas Scottish Rite Hospital for Children Purchases Carestream's DRX-Evolution

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1084  


ASTROMAN Magazine – 2011.09.18

GE Healthcare to Invest $1 Billion in New Oncology Solutions

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1060  


ASTROMAN Magazine – 2011.09.12

WellPoint and IBM Announce Agreement to Put Watson to Work in Health Care

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1056  


ASTROMAN Magazine – 2011.08.28

Saskatchewan and Hitachi Sign R&D Agreement on Nuclear Medicine Technology

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1044  


ASTROMAN Magazine – 2011.08.21

IBM Unveils Cognitive Computing Chips

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1042  


ASTROMAN Magazine – 2011.07.11

GE Healthcare Wins Design Excellence Awards for Magnetic Resonance Imaging

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1017  


ASTROMAN Magazine – 2011.06.04

GE Healthcare Opens Life Sciences Demonstration Laboratory in Stockholm, Sweden

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=986  


ASTROMAN Magazine – 2011.04.30

Metropolitan Chicago Healthcare Council to Develop Nation's Largest Metro Health Information Exchange

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=959  


ASTROMAN Magazine – 2011.04.28

Microsoft Implements Chronic Condition Management Platform at Denver Health

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=958  


ASTROMAN Magazine – 2011.04.07

Verizon and MEDfx Demonstrate Digital Exchange of Health Care Records

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=935  


ASTROMAN Magazine – 2011.03.31

Micromedex CareNotes Available Within the Iatric Systems Patient Discharge Module

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=931  


ASTROMAN Magazine – 2011.02.20

IBM to Collaborate with Nuance to Apply IBM's "Watson" Analytics Technology to Healthcare

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=899  


ASTROMAN Magazine – 2011.01.23

Siemens Healthcare unveils the world's first integrated whole-body molecular MR system available for clinical use

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=887  


ASTROMAN Magazine – 2011.01.10

IBM and the Premier Healthcare Alliance to Integrate Nation's Healthcare Data

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=879  


ASTROMAN Magazine – 2010.12.25

Accuray Establishes Medical Affairs Function to accelerate CyberKnife

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=862  


ASTROMAN Magazine – 2010.11.07

New AT&T ForHealth Practice Accelerates Pursuit of $34 Billion

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=840  


ASTROMAN Magazine – 2010.04.18

Fujitsu and TUM Develop World's First DNA-based Revolutionary Bio-Sensor Technology

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=703  


ASTROMAN Magazine – 2009.12.23

Canon Inc. to make OPTOPOL Technology S.A. of Poland a subsidiary

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=624  


ASTROMAN Magazine – 2009.09.05

Toshiba's Aquilion ONE Honored With Medical Design Excellence Gold Award

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=568